Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,511 Anemia
clinical trials

Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Grady Health System
mi
from
Atlanta, GA
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Augusta University Medical Center
mi
from
Augusta, GA
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
MUSC, Investigational Drug Services
mi
from
Charleston, SC
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
The Ohio State University James Comprehensive Cancer Hospital & Solove Research Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Miami Valley Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Golisano Children's Hospital of Southwest Florida
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Louisville Health Sciences Center
mi
from
Louisville, KY
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
UPMC - Hillman Cancer Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Family Medicine Center
mi
from
Savannah, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Macitentan in Pulmonary Hypertension of Sickle Cell Disease
Status: Enrolling, Phase I
Updated: 12/31/1969
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Psychiatry / Psychology Clinical Trial
Cognitive Behavioral Therapy and Real-time Self-management Intervention for SCD Via Mobile Applications
Status: Enrolling, Phase I, II
Updated: 3/1/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease
Status: Enrolling, Phase I
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Akron, OH
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Augusta, GA
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Cerritos, CA
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Columbia, SC
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Doral, FL
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Doylestown, PA
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Evergreen Park, IL
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Fairfax, VA
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Glendale, CA
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Hudson, FL
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Jackson, MS
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
La Palma, CA
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Lancaster, PA
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Mentor, OH
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Riverside, CA
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Salisbury, NC
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Springfield, IL
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Upland, CA
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
Status: Enrolling, Phase II
Updated: 4/30/2018
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
Status: Enrolling, Phase II
Updated: 4/30/2018
Dana Farber Cancer Institute/Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
Status: Enrolling, Phase II
Updated: 4/30/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
Status: Enrolling, Phase II
Updated: 4/30/2018
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
Status: Enrolling, Phase II
Updated: 4/30/2018
University of Texas Health Sciences Center
mi
from
Houston, TX
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
Status: Enrolling, Phase II
Updated: 4/30/2018
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
Status: Enrolling, Phase II
Updated: 4/30/2018
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling, Phase II
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling, Phase II
Updated: 12/31/1969
Northside Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling, Phase II
Updated: 12/31/1969
Johns Hopkins Unversity
mi
from
Baltimore, MD
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling, Phase II
Updated: 12/31/1969
Karmanos Cancer Institute/Children's Hospital of Michigan
mi
from
Detroit, MI
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Florida College of Medicine
mi
from
Gainesville, FL
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling, Phase II
Updated: 12/31/1969
Penn State College of Medicine, Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Mercy Hospital and Clinics
mi
from
Kansas City, MO
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Pennsylvania Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling, Phase II
Updated: 12/31/1969
Washington University/ Barnes-Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling, Phase II
Updated: 12/31/1969
Stanford Hospital and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Severe Aplastic Anemia Clinical Trial
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Status: Enrolling, Phase II
Updated: 12/31/1969
H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Hemophilia A Clinical Trial
BAX 855 Previously Untreated Patient (PUP)
Status: Enrolling, Phase III
Updated: 4/19/2018
Penn State M.S. Hershey Med Ctr
mi
from
Hershey, PA
Click here to add this to my saved trials
Hemophilia A Clinical Trial
BAX 855 Previously Untreated Patient (PUP)
Status: Enrolling, Phase III
Updated: 4/19/2018
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Iron Deficiency Clinical Trial
Neuroimaging of Donor Iron Deficient Study
Status: Enrolling, Phase
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Transplantation Using Reduced Intensity Approach for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone Marrow
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hematology Clinical Trial
The Hemophilia Ultrasound Project
Status: Enrolling, Phase
Updated: 12/31/1969
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases Clinical Trial
NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Pathophysiology of Acute Pain in Patients With Sickle Cell Disease
Status: Enrolling, Phase
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Jackson, MS
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Middlebury, CT
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Mineola, NY
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
STRIDE Biorepository
Status: Enrolling, Phase
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
STRIDE Biorepository
Status: Enrolling, Phase
Updated: 12/31/1969
University of Michigan Medical Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
STRIDE Biorepository
Status: Enrolling, Phase
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
STRIDE Biorepository
Status: Enrolling, Phase
Updated: 12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
STRIDE Biorepository
Status: Enrolling, Phase
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
STRIDE Biorepository
Status: Enrolling, Phase
Updated: 12/31/1969
University of Florida at Gainsville
mi
from
Gainesville, FL
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
STRIDE Biorepository
Status: Enrolling, Phase
Updated: 12/31/1969
Children's Hospital of New Orleans
mi
from
New Orleans, LA
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
STRIDE Biorepository
Status: Enrolling, Phase
Updated: 12/31/1969
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
STRIDE Biorepository
Status: Enrolling, Phase
Updated: 12/31/1969
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
STRIDE Biorepository
Status: Enrolling, Phase
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
STRIDE Biorepository
Status: Enrolling, Phase
Updated: 12/31/1969
Childrens National Medical Center
mi
from
Washington DC,
Click here to add this to my saved trials
Hematology Clinical Trial
Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias
Status: Enrolling, Phase IV
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Alexandria Cardiology Clinic
mi
from
Alexandria, LA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Cardiovascular Research Institute of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Sparks Regional Medical Center
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Cardiovascular Institute of the South
mi
from
Houma, LA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
UF Health Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Vista Health Research, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Trinity Health Center - Medical Arts
mi
from
Minot, ND
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Wenatchee Valley Hospital and Clinics
mi
from
Wenatchee, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Alfieri Cardiology
mi
from
Wilmington, DE
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
PMG Research of Wilmington
mi
from
Wilmington, NC
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Gastroenterology, Hematology, Neurology, Oncology, Other Clinical Trial
Familial Investigations of Childhood Cancer Predisposition
Status: Enrolling, Phase
Updated: 12/31/1969
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
1 … 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 … 25